Rinvoq Prices, Coupons, Copay Cards & Patient Assistance
Rinvoq (upadacitinib) is a member of the antirheumatics drug class and is commonly used for Ankylosing Spondylitis, Atopic Dermatitis, Crohn's Disease, and others.
The cost for Rinvoq 15 mg oral tablet, extended release is around $6,782 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Rinvoq is available as a brand name drug only, a generic version is not yet available. View generic Rinvoq availability for more details.
Rinvoq prices
Oral Tablet, Extended Release
15 mg
Rinvoq oral tablet, extended release
from $6,781.56
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $226.05 | $6,781.56 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
30 mg
Rinvoq oral tablet, extended release
from $6,781.56
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $226.05 | $6,781.56 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
45 mg
Rinvoq oral tablet, extended release
from $12,650.55
for 28 tablets
Quantity | Per unit | Price |
---|---|---|
28 | $451.81 | $12,650.55 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Rinvoq Coupons, Copay Cards and Rebates
Rinvoq offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Rinvoq Complete Savings Card
Eligible commercially insured patients may pay as little as $5 per monthly prescription; maximum savings of $14,000 per calendar year.
- Applies to:
- Rinvoq
- Number of uses:
- per prescription per calendar year
Form more information phone: 800-274-6867 or Visit website
Rinvoq Complete Rebate Program
Eligible commercially insured patients may submit a rebate request if the pharmacy was unable to process the Savings Card; patient must pay for their prescription in full in order to be eligible for this offer.
- Applies to:
- Rinvoq
- Number of uses:
- One rebate per prescription fill
Form more information phone: 800-274-6867 or Visit website
Rinvoq Complete Rebate Program for Lab Tests
Eligible commercially insured patients may submit a rebate request through this program for certain lab tests not covered by insurance that are used to monitor for specific parameters as recommended in the product label.
- Applies to:
- Rinvoq
- Number of uses:
- Per year
Form more information phone: 800-274-6867 or Visit website
Rinvoq Medicare Part D Extra Help Subsidy
Patients with Medicare Part D coverage may be eligible for the Extra Help Subsidy, which may lower premiums and prescription costs. Contact the program for more information.
- Applies to:
- Rinvoq
- Number of uses:
- Per prescription until program expires
Form more information phone: 800-772-1213 or Visit website
Patient Assistance & Copay Programs for Rinvoq
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Rinvoq (upadacitinib) Tablet; Extended-Release
- Rinvoq LQ (upadacitinib) Solution; Oral
More information please phone: 866-316-7263 Visit Website
Provider: myAbbVie Assist for Rinvoq
Eligibility requirements:- Must be uninsured or underinsured
- At or below 600% of FPL
- Not applicable
- Must reside in the US and be under the direct care of a US physician
- Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis. Contact program for details.
- Rinvoq (upadacitinib) Tablet; Extended-Release
- Rinvoq LQ (upadacitinib) Solution; Oral
More information please phone: 800-222-6885 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Rinvoq (upadacitinib)
- Check interactions
- Compare alternatives
- Reviews (197)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español